insmredbird • Jul 6, 2013 5:09 PM Flag
More Arikace-treated patients reported adverse events in the study compared to patients treated with TOBI. Eleven Arikace patients reported severe side effects compared to five patients on TOBI.
If you enjoy that the primary endpoint of non-inferiority,then yes it did/the secondary data was oddly missing from the company/unless it has been disseminated since.biowatchers wanted superiority/they didn't get it. The drug has been delayed another 2years in the US.